Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cadila Pharmaceuticals Ltd.

www.cadilapharma.com

Latest From Cadila Pharmaceuticals Ltd.

Graft Trail: Top Level Indian Regulatory Official Arrested

The arrest of India's deputy drugs controller creates shock waves and indicates an intent to clamp down on graft at any level, say industry experts.

Regulation Legal Issues

Deal Watch: Are Ultragenyx, REGENXBIO In A Bidding War For Dimension?

ProQR spinout Amylon gets started by licensing four central nervous system disorder candidates from its parent, while start-up Eyevance gets US rights to Nicox’s Zerviate.

Deals M & A

Scrip 100: The Architecture Of A Top Heavy Industry

Pharmaceutical revenues were down slightly; so was R&D spending, thanks to a strengthening dollar. Scrip analyzes 620 companies and uses numbers, clocks and tiers to paint some data pictures of the pharmaceutical industry in 2015.

Commercial Market Intelligence

Tuberculosis: An Old Killer Proving Difficult To Best

With the announcement that tuberculosis surpassed HIV/AIDS in attributable deaths from infectious diseases worldwide, there has been a renewed interest in the development of new treatments and regimens for dealing with what is now the world’s number one infectious disease killer.

Research & Development Infectious Diseases
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Cadila Pharmaceuticals Ltd.
  • Senior Management
  • Rajiv Modi, MSc, PhD, Chmn. & Managing Dir.
  • Contact Info
  • Cadila Pharmaceuticals Ltd.
    Phone: (91) 2718 225001
    Sarkhej-Dholka Rd.
    Bhat, 382 210
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register